TPMPA (hydrate)
CAY-24302-25 25 mg
Data Sheet: 
SDS:
SDS:
Formulation
A crystalline solid
Purity
≥95%
MW
161,138781
Shipment
-20
Long Term Storage
-20
Shelf Life
1460
Description
A selective GABAA-ρ1 (ρ1 GABAC) receptor antagonist (Kbs = 2 and 16 μM for GABAA-ρ1 over GABAA-ρ2, respectively); blocks the inhibitory effect of 3-APMPA on EPSCs in rat hippocampal slices (EC50 = 490 μM); increases light sensitivity and the maximal response of rat retinal ganglion cells without altering their dynamic range (100 μM); increases waking from 45 to 62% compared to vehicle control and decreases slow-wave and REM by 11 and 5.4%, respectively, in rats (50 μg, i.c.v.)
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).
